Evaluate the Safety and Efficacy of Caspofungin Acetate as Empirical Therapy in Chinese Adults With Persistent Fever and Neutropenia (0991-055)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Dyslipidemia in Type 2 Diabetes (0767-034)
- Status
- TERMINATED
- Phase
- PHASE3
ZOSTAVAX™ in Patients on Chronic/Maintenance Corticosteroids (V211-017) (COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE2
GEM 1.5 mg b.i.d. to 4.5 mg b.i.d. Versus Lorazepam in GAD (0777-026)
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate the Effectiveness of Cosopt® as First Line Therapy (MK-0507A-153)
- Status
- COMPLETED
- Phase
- PHASE3
Addition Of Januvia (Sitagliptin) Improves Glycemic Control In Patients Inadequately Controlled By Metformin (MK0431-078)
- Status
- COMPLETED
- Phase
- PHASE3
Dry Eye Study With Cosopt® Over 8 Weeks in Patients With Open-Angle Glaucoma or Ocular Hypertension (0507A-152)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy and Tolerability of MK0533 in Patients With Type 2 Diabetes (0533-005)
- Status
- TERMINATED
- Phase
- PHASE2
A Study of MK0777 in the Treatment of Outpatients With Generalized Anxiety Disorder (0777-020)
- Status
- COMPLETED
- Phase
- PHASE2
MK0782 + Low-Dose Aspirin 7-Day Erosion Endoscopy Study (0782-001)
- Status
- COMPLETED
- Phase
- PHASE2
MK0767 Added to Insulin Therapy in Patients With Type 2 Diabetes (0767-030)
- Status
- TERMINATED
- Phase
- PHASE3
Placebo Controlled Metformin and Sulfonylurea Combination Study in Patients With Type 2 Diabetes (0767-025)
- Status
- TERMINATED
- Phase
- PHASE3
MK0767 and Metformin Combination Study (0767-028)
- Status
- TERMINATED
- Phase
- PHASE3
MK0916 in Patients With Type 2 Diabetes and Metabolic Syndrome (0916-005)
- Status
- COMPLETED
- Phase
- PHASE2
MK0767 in Type 2 Diabetes (0767-012)
- Status
- TERMINATED
- Phase
- PHASE2
Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001)
- Status
- COMPLETED
- Phase
- PHASE3
Pediatric Expanded Access Program-Oral Solution (0831-908)
- Status
- COMPLETED
- Phase
- PHASE3
Study A - MK0767 Monotherapy Study
- Status
- TERMINATED
- Phase
- PHASE3
MK0767 and Sulfonylurea Combination Study (0767-027)
- Status
- TERMINATED
- Phase
- PHASE3
12-Week No-Rofecoxib Plus Aspirin Endoscopy Study (0782-003)
- Status
- TERMINATED
- Phase
- PHASE2